How the Food and Drug Administration will approach measuring the benefits of these drugs for the purpose of approving them is uncertain. FDA draft guidelines published in January say loss of lean ...

Burris says the greatest hope for the new drug might be in maintaining muscle mass during weight loss – which often threatens ...

“The body of evidence for the GLP-1 drug class shows that up to 40% of total weight loss in GLP-1 patients is lean body mass including skeletal muscle mass, 1 ” said Mitchell Glass, M.D ...